Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > New Financing
View:
Post by PeterG on Mar 23, 2023 12:36pm

New Financing

This is again a dark day for all of the trustful longterm shareholders. 12% interest per annum, many more cheap shares for the management. And on top of that, Howard will get a lot of cheap warrants. Pretty nice!! Good deal Howard, Michelle and Chris. Congrats
Comment by emerald03 on Mar 23, 2023 1:08pm
Yup, more  inevitable dilution for us common shareholders, each share we own is worth less and less progressively, thanks to   deal negotiation  incompetence. 
Comment by forhandlaren on Mar 23, 2023 1:48pm
I'm not prepared to call the deal with Abbvie incompetent as I don't know all aspects. The milestones are not public nor the royalty rate or anticipated market share. That said, I was pretty upset about the upfront - far from my expectations. I think this deal was tailorized for a buyout, meaning that the future revenue stream is more worth than a big upfront now. But with the R+F ...more  
Comment by lscfa on Mar 23, 2023 2:35pm
Non-brokered offering. I suspect the terms were set by an interested institutional investor who wants in dirt cheap and at low risk.
Comment by navajojoe on Mar 23, 2023 5:25pm
This post has been removed in accordance with Community Policy
Comment by lscfa on Mar 23, 2023 5:35pm
You know nothing. Institution investors invest in nice round $250,000 chunks. SBM probably hoping to sell the debentures to 4 funds for $1 million.
Comment by lscfa on Mar 23, 2023 5:46pm
March 2014 - Sirona Biochem Corp. (TSXV:SBM) announced a non-brokered private placement of 9,230,770 units at CAD 0.13 per unit for gross proceeds of CAD 1,200,000 on February 25, 2014. The transaction will include participation from a new investor, AlphaNorth Asset Management.
Comment by MirrorWorldMan on Mar 24, 2023 9:44am
Guaranteed dilution to pay interest and principal for holders of debentures/warrants. How else will it br paid? By future revenue? We all know the odds of that... So Howie is borrowing more money, issuing nore shares again, to pay for salaries.  All he knows how to do is dilute. Investing his own money at a high rate in his own company to pay himself and then issueing shares in the future to ...more  
Comment by lscfa on Mar 24, 2023 10:17am
If this new financing goes to just a few large investors just how much more info are they getting than us retail schmucks?
Comment by MirrorWorldMan on Mar 24, 2023 6:39pm
Whoever new (if any) who comes on board will soon suffer the realization that we all have. Howie continues to milk a dying cow with costant drainage of resources and diluting a shriveled utter. You think when we are sitting at .085 he may start to think crisis management. 
Comment by SleepyHoward on Mar 24, 2023 11:06am
True words. The question is what can we do again against howard verrico?  Is there a chance for us shareholders? Maybe everybody can write something on Twitter because everybody can read it and maybe they thing about it that howard is poison for the company
Comment by lscfa on Mar 31, 2023 6:23pm
You would think Abbvie would want its supplier of 1067 to be financially sound to ensure supply. Why the hell does mgmt beg Abbvie for a loan?
Comment by lscfa on Mar 31, 2023 6:23pm
Doesn't
Comment by Pareto8020 on Apr 01, 2023 8:20am
Why wouldn't they just BUY SBM out at this price and save themselves the $680M they will supposedly be paying out over the lifetime of the patent? Even if they bought SBM for .50 or a 1.00 they'd have the lightener and the whole lot of compounds for way less than royalties. 
Comment by MirrorWorldMan on Apr 02, 2023 6:59pm
AbbVie likes to do strategic partnerships with small companies to diversify their portfolio without investing all the own R &D expenses.  Purchasing the companies means they have to manufacture a bunch of diverse molecules with radically different development processes originating from multitude labs. Its cleaner to just be raw ingredients over time and sever any deal if things do not ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities